Novel stem-cell transplant continues to show promise for achieving full insulin independence for individuals with type 1 diabetes.
Trevor W. Reichman, MD, PhD, Surgical Director of Pancreas and Islet Cell Transplantation, Ajmera Transplant Center at the University of Toronto said: “We are hopeful that this first-of-its-kind research could be a gamechanger for the treatment of type 1 diabetes.”